GSK plc vs Open Text Corporation — how do they compare? GSK plc trades at $52.85 (market cap $101.34B), while Open Text Corporation trades at $23.41 (market cap $5.45B). The key difference: GSK plc is far larger — about 18.6× Open Text Corporation's market cap, and Open Text Corporation pays the higher dividend (4.84%). Which is the better fit depends on your goals.
| GSK | OTEX | |
|---|---|---|
Market Cap | $101.34B | $5.45B |
Sector | Health | Technology |
52-Week High | $61.18 | $39.69 |
52-Week Low | $36.20 | $20.01 |
Enterprise Value | $121.95B | $10.61B |
Dividend Yield | 3.49% | 4.84% |
Signals from Pluang's Aura AI — not financial advice
GSK trades at $52.64, up 2.7% on the day, with a bearish technical signal despite recent earnings beats. The company reported Q1 2026 EPS of $1.24, beating estimates of $1.16, and maintains strong profitability with a 17.78% net income margin. Positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline strength, while a pending acquisition of Nuvalent, Inc. signals strategic expansion.
GSK offers value with a P/E of 13.71 and stable cash flows, but faces risks from clinical setbacks, as seen in the terminated Alector partnership. Analyst sentiment is mixed with 31% buy ratings, reflecting cautious optimism amid competitive and regulatory pressures. The stock's outlook hinges on execution of growth initiatives and pipeline developments.
OTEX trades at $23.49, up 4.54% today, with a bearish technical signal but strong fundamentals including a P/E of 11.04 and consistent earnings beats. Recent news highlights a $105 million investment in Europe to expand AI and cloud capabilities, alongside a completed divestiture of Vertica for $150 million, signaling strategic focus.
The stock offers value with a consensus price target of $29.75, implying 27% upside, though technical weakness and modest profitability metrics like 9.91% net margin pose near-term risks. Long-term growth hinges on successful AI integration and debt management amid competitive pressures.
Trailing returns across standard periods
Latest headlines on both assets
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.
Read more on OTEX →